Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ESSA Pharma Inc. - Common Stock (NQ: EPIX )

1.600 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ESSA Pharma Inc. - Common Stock

< Previous 1 2 Next >
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results
Via Benzinga
Exposures Fossil Fuels
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
Via Benzinga
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
Via Benzinga
Topics Stocks
Exposures US Equities
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
ESSA Pharma terminates its Phase 2 masofaniten trial in prostate cancer after interim data shows no added efficacy over enzalutamide alone, shifting focus to other priorities. 
Via Benzinga
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ESSA Pharma: Q1 Earnings Insights
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday! 
Via InvestorPlace
EPIX Stock Earnings: ESSA Pharma Misses EPS for Q2 2024
EPIX stock results show that ESSA Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With Prostate Cancer Focused ESSA Pharma Stock Today?
ESSA Pharma shares fell 22.6% at $6.80 yesterday. Explore masofaniten's promising Phase 1/2 results in prostate cancer treatment. Updated data, PSA reductions, and financial strength. 
Via Benzinga
Recap: ESSA Pharma Q4 Earnings
Via Benzinga
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. 
Via Benzinga
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
EPIX Stock Earnings: ESSA Pharma Beats EPS for Q4 2023
EPIX stock results show that ESSA Pharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. 
Via Benzinga
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves. 
Via Benzinga
ESSA Pharma: Q2 Earnings Insights
ESSA Pharma (NASDAQ:EPIX) reported its Q2 earnings results on Tuesday, May 9, 2023 at 07:00 AM. Here's what investors need to know about the announcement. Earnings ESSA Pharma beat estimated earnings... 
Via Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, investor! We're diving into the biggest pre-market stock movers for Monday as we get ready for another week of trading! 
Via InvestorPlace
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its... 
Via Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... 
Via Benzinga
ESSA Pharma Shares Tank As Janssen Stops Enrollment In EPI-7386 Combo Prostate Cancer Trials
Via Benzinga
$8.2 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed higher by more than 800 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers as we check out the latest stock news for Thursday morning! 
Via InvestorPlace
Why Meta Platforms Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
Gainers View, Inc. (NASDAQ: VIEW) rose 23.2% to $1.30 in pre-market trading after declining 9% on Wednesday. 
Via Benzinga
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the... 
Via Benzinga
Nasdaq Drops Over 200 Points; Microsoft Shares Down After Q1 Results
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. 
Via Benzinga
Mullen (MULN) Stock Heats Up on Expanded Promotional Tour
Mullen (MULN) stock is moving on Wednesday as investors prepare for the electric vehicle (EV) company's expanded promotional tour. 
Via InvestorPlace
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.